Mark Fereshteh
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Estrogen and related hormone effects
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 3
-
- Single-cell and spatial transcriptomics 3
- Hedgehog Signaling Pathway Studies 2
- Co-authors
- Tannishtha Reya (3 shared papers)Philip A. Beachy (2 shared papers)Hyog Young Kwon (2 shared papers)Michael J. Munchhof (1 shared paper)Catriona Jamieson (1 shared paper)Alan Chen (1 shared paper)Annelie Abrahamsson (1 shared paper)Todd VanArsdale (1 shared paper)
- Journals
- Cancer Research (5 papers)SLAS DISCOVERY (3 papers)ACS Central Science (1 paper)Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Mark Fereshteh
17 papers receiving 1.5k citations
Mark Fereshteh's Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 256
- Genetics 180
- Oncology 429
- Molecular Biology 1.0k
- Genetics 208
Countries citing papers authored by Mark Fereshteh
This map shows the geographic impact of Mark Fereshteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fereshteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fereshteh more than expected).
Fields of papers citing papers by Mark Fereshteh
This network shows the impact of papers produced by Mark Fereshteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fereshteh. The network helps show where Mark Fereshteh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Fereshteh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia Hit paper breakdown → | 2009 | 711 |
| 2 | 2010 | 434 | |
| 3 | 2008 | 88 | |
| 4 | 2007 | 58 | |
| 5 | 2012 | 49 | |
| 6 | 2008 | 48 | |
| 7 | 2014 | 43 | |
| 8 | 2015 | 37 | |
| 9 | 2001 | 21 | |
| 10 | 2018 | 6 | |
| 11 | 2016 | 6 | |
| 12 | 2018 | 3 | |
| 13 | 2021 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2021 | 0 | |
| 19 | 2022 | 0 |
About Mark Fereshteh
Mark Fereshteh is a scholar working on Oncology, Molecular Biology, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers), Single-cell and spatial transcriptomics (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Estrogen and related hormone effects (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Hematology (256 citations), Genetics (180 citations), Oncology (429 citations), Molecular Biology (1.0k citations) and Genetics (208 citations). Mark Fereshteh has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Tannishtha Reya, Philip A. Beachy, Hyog Young Kwon, Michael J. Munchhof, Catriona Jamieson, Alan Chen, Annelie Abrahamsson, Todd VanArsdale, John P. Chute and David A. Rizzieri. Their work appears in journals such as Cancer Research, SLAS DISCOVERY, ACS Central Science, Nature and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.